Zobrazeno 1 - 10
of 11 719
pro vyhledávání: '"autologous stem‐cell transplantation"'
Autor:
Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Byung-Hyun Lee, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim, Ka-Won Kang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract High-dose melphalan at 200 mg/m2 (MEL-200) is the standard conditioning regimen before autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM). Busulfan (BU) and cyclophosphamide (CY) can be used as alternatives wh
Externí odkaz:
https://doaj.org/article/00229a6dc8b7438a93cc2609a273eea6
Autor:
Kaloyannidis P, George B, Alrustamani A, Khalil C, Al-Charfli B, Al-Moghrabi N, Ibrahim D, Alfar M, Daryahya M, Mheidly K, El-Saddik A, Al-Shamsi HO
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 471-475 (2024)
Panayotis Kaloyannidis,1 Biju George,1 Ahmad Alrustamani,1 Charbel Khalil,1 Basmah Al-Charfli,1 Nour Al-Moghrabi,1 Dima Ibrahim,2 Mohammed Alfar,3 Mohammed Daryahya,1 Kayane Mheidly,4 Amro El-Saddik,1 Humaid O Al-Shamsi5– 11 1Adult Hematology & Cel
Externí odkaz:
https://doaj.org/article/953b2ac953e64c61945c0b09e0128c4a
Autor:
Lorenzo Cillo, Anna Benedetta Dalla Palma, Stefania Ricci, Mario Pedrazzoni, Matteo Scita, Matia Bernardi, Gabriella Sammarelli, Laura Pelagatti, Nicola Giuliani
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 892-895 (2024)
Abstract A portion of multiple myeloma (MM) patients relapse early or do not respond to first line treatment. Identification of possible clinical and or biological features of these patients remains an unmet medical need. In this study we assesed the
Externí odkaz:
https://doaj.org/article/126f450d460946a682d7443b6b362ca5
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-4 (2024)
Abstract Despite the global vaccination campaigns, certain patient groups remain highly vulnerable to SARS-CoV-2 and are at high risk for unfavorable COVID-19 outcomes. As previously shown by our group and a more recent report by Chang Su and coworke
Externí odkaz:
https://doaj.org/article/8a02b22926f4416e90d81424a8c846d0
Autor:
Amany R. Keruakous, Laura Walker, Molly Denlinger, Mohammad A. H. Mian, Danielle Bradshaw, Vamsi K. Kota, Anand P. Jillella
Publikováno v:
Hematology Reports, Vol 16, Iss 3, Pp 479-486 (2024)
Background/Objectives: High-dose chemotherapy (HD-CHT) followed by autologous stem cell transplantation (ASCT) remains the gold standard for eligible multiple myeloma (MM) patients, even amidst evolving therapeutic options. Clinical trials have demon
Externí odkaz:
https://doaj.org/article/aa371a726fa04e75a1edc884c3983e5f
Autor:
Jari Intra, Sara Pezzatti, Rinaldo Brivio, Monica Carpenedo, Rita Romano, Nadia Spinoni, Marco Casati
Publikováno v:
International Journal of Translational Medicine, Vol 4, Iss 3, Pp 498-504 (2024)
Immunoglobulin D (IgD) myeloma represents an uncommon subtype of multiple myeloma (MM), accounting for 1–2% of cases. Subjects affected by IgD MM have been demonstrated to have an inferior outcome and survival compared to those with other MM subtyp
Externí odkaz:
https://doaj.org/article/be54552a107549f682fde6284356a9cf
Autor:
Michele Clerico, Simone Ferrero, Beatrice Alessandria, Gian Maria Zaccaria, Elisa Genuardi, Simone Ragaini, Rita Tavarozzi, Federica Cavallo, Stefan Hohaus, Gerardo Musuraca, Angelo Michele Carella, Caterina Stelitano, Monica Tani, Gianluca Gaidano, Jacopo Olivieri, Sara Veronica Usai, Sara Galimberti, Francesca Re, Michael Mian, Claudia Castellino, Vincenzo Pavone, Andrea Evangelista, Benedetto Bruno, Sergio Cortelazzo, Roberto Passera, Marco Ladetto
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract In the frontline high-dose phase 3 FIL-MCL0208 trial (NCT02354313), 8% of enrolled mantle cell lymphoma (MCL) patients could not be randomised to receive lenalidomide (LEN) maintenance vs observation after autologous stem cell transplantatio
Externí odkaz:
https://doaj.org/article/0fb90bbb8fcd4300b5901399a273825b
Autor:
Diego Vinicius Santinelli-Pestana, Livia Netto Chaer, Livia Mariano, Leonardo Jun Otuyama, Alfredo Medrone Junior, Vanderson Rocha
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 3, Pp 256-260 (2024)
Introduction: Autologous hematopoietic stem cell transplantation (ASCT) is the long-term consolidation treatment for various hematological malignancies. The collection of hematopoietic stem cell yield is critical to successful ASCTs, but not always a
Externí odkaz:
https://doaj.org/article/dbe12a40f6554623925c2f5399a3c081
Publikováno v:
Cancer Medicine, Vol 13, Iss 23, Pp n/a-n/a (2024)
ABSTRACT Background Peripheral T‐cell lymphomas (PTCL) frequently result in relapsed or refractory diseases. Upfront autologous hematopoietic stem cell transplantation (ASCT) using the BEAM (carmustine, etoposide, cytarabine, and melphalan) regimen
Externí odkaz:
https://doaj.org/article/0c6142d8bac347dd86b98ac12b9a7db5
Autor:
Jackson Griffith-Linsley, William Robert Bell, Aaron Cohen-Gadol, Diane Donegan, Angela Richardson, Michael Robertson, Kevin Shiue, Kathryn Nevel
Publikováno v:
CNS Oncology, Vol 13, Iss 1 (2024)
Aim: Atypical teratoid rhabdoid tumor (ATRT) is a rare and highly aggressive primary CNS neoplasm, predominantly observed in children. The use of autologous stem cell transplantation (ASCT) in pediatric ATRT has shown promise; however, its utility in
Externí odkaz:
https://doaj.org/article/a02ff59be0144b56b83a1c61d7e80578